查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375472

生物样本库市场：按产品、样本类型、储存类型、应用和最终用户 - 2023-2030 年全球预测

Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

生物银行市场预计将从 2022 年的 634.5 亿美元增至 2030 年的 1,527.5 亿美元，预测期内年复合成长率为 11.60%。

全球生物样本库市场

主要市场统计
市场金额：基准年 [2022] 634.5亿美元
预计市场价值 [2023] 703.3亿美元
预计市场量[2030] 1527.5亿美元
年复合成长率（%） 11.60%
生物样本库市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵是评估生物样本库市场的重要工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1. 生物银行市场的市场规模与预测是多少？

2. 生物样本库市场中哪些产品、细分市场、应用和领域具有最高的投资潜力？

3.生物样本库市场的竞争策略架构是什么？

4. 生物样本库市场的最新技术趋势和法律规范是什么？

5. 生物样本库市场主要供应商的市场占有率为何？

6. 进入生物样本库市场的合适型态和策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 各国慢性病负担日益加重以及需要更好的医疗基础设施
      • 扩大私人和公共对药物研究的投资
      • 人们对再生医学和政府配合措施的认识不断增强
    • 抑制因素
      • 由于生物样本库的分散性质而导致程序统一的相关问题
    • 机会
      • 正在进行的研究以改进和确保生物样本库资料收集和分析的标准化
      • 新的重点是生物样本库的永续性和成像生物样本库的发展
    • 任务
      • 与生物样本库相关的道德和法律问题
  • 市场区隔分析
    • 产品：扩展软体整合以简化生物样本库操作
    • 样本类型：增加核酸样本在基因研究的使用
    • 储存类型：效率和可扩展性使自动化储存系统日益受到重视
    • 最终用户：扩大製药业生物库的药物开发
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章生物样本库市场：副产品

  • 介绍
  • 消耗品
  • 设备与设备
  • 服务
  • 软体

第7章生物样本库市场：依样本类型

  • 介绍
  • 体液
  • 血液製品
  • 细胞株
  • 人体组织
  • 核酸

第8章生物样本库市场：依储存类型

  • 介绍
  • 自动的
  • 手动的

第9章生物样本库市场：依应用分类

  • 介绍
  • 临床调查
  • 生命科学研究
  • 再生医学

第10章生物样本库市场：按最终用户分类

  • 介绍
  • 学术研究所
  • 医院
  • 製药和生物技术

第11章美洲生物样本库市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第12章亚太生物样本库市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第13章欧洲、中东和非洲的生物样本库市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 竞争情境分析：主要企业
    • 併购
    • 合约、合作和伙伴关係
    • 投资、资金筹措

第15章竞争组合

  • 主要企业简介
    • AMS Biotechnology（Europe）Limited
    • ASKION GmbH
    • Avantor, Inc.
    • Azenta Life Sciences
    • Bay Biosciences LLC
    • Becton, Dickinson and Company
    • BioIVT LLC
    • BioKryo by L'AIR LIQUIDE SA
    • BocaBio
    • Charles River Laboratories International, Inc.
    • Cryoport Systems, LLC
    • CTIBiotech
    • Cureline, Inc.
    • Firalis Group
    • Greiner AG
    • Hamilton Company
    • Merck KgaA
    • Micronic Holding BV
    • PHC Holdings Corporation
    • Promega Corporation
    • ProteoGenex
    • QIAGEN NV
    • Sopachem NV/SA
    • SPT Labtech Ltd.
    • STEMCELL Technologies Inc.
    • Taylor-Wharton
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • UK Biobank Limited
    • US Biolab Corporation, Inc.
  • 主要产品系列

第16章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-961BA04A2DC4

The Biobanking Market is projected to reach USD 152.75 billion by 2030 from USD 63.45 billion in 2022, at a CAGR of 11.60% during the forecast period.

Global Biobanking Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 63.45 billion
Estimated Year Value [2023] USD 70.33 billion
Forecast Year Value [2030] USD 152.75 billion
CAGR (%) 11.60%
Biobanking Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biobanking Market.

Based on Product, market is studied across Consumables, Equipment & Instruments, Services, and Software. The Services is projected to witness significant market share during forecast period.

Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids. The Biological Fluids is projected to witness significant market share during forecast period.

Based on Storage Type, market is studied across Automated and Manual. The Automated is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine. The Regenerative Medicine is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceutical & Biotechnology. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.91% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biobanking Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biobanking Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L'AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Biobanking Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Biobanking Market?

3. What is the competitive strategic window for identifying opportunities in the Biobanking Market?

4. What are the latest technology trends and regulatory frameworks in the Biobanking Market?

5. What is the market share of the leading vendors in the Biobanking Market?

6. Which modes and strategic moves are suitable for entering the Biobanking Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biobanking Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
      • 5.1.1.2. Growing private and public investments in pharmaceutical research
      • 5.1.1.3. Rising awareness and government initiatives in regenerative medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with procedure harmonization due to decentralized nature of biobanks
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
      • 5.1.3.2. Emerging focus on biobank sustainability and development of imaging biobanks
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and legal concerns associated with biobanking
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding software integration to facilitate the biobanking operations
    • 5.2.2. Sample Type: Increasing use of nucleic acid sample for genetic study
    • 5.2.3. Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
    • 5.2.4. End-User: Expansion of biobanks in pharmaceutical sector for drug development
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biobanking Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment & Instruments
  • 6.4. Services
  • 6.5. Software

7. Biobanking Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Fluids
  • 7.3. Blood Products
  • 7.4. Cell Lines
  • 7.5. Human Tissues
  • 7.6. Nucleic Acids

8. Biobanking Market, by Storage Type

  • 8.1. Introduction
  • 8.2. Automated
  • 8.3. Manual

9. Biobanking Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Research
  • 9.3. Life Science Research
  • 9.4. Regenerative Medicine

10. Biobanking Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Hospitals
  • 10.4. Pharmaceutical & Biotechnology

11. Americas Biobanking Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biobanking Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biobanking Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Crown Bioscience to Acquire Indivumed's Service Business and Supporting Biobank
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. New biobanking partnership safeguards the genetic diversity of America's endangered species
    • 14.3.3. Investment & Funding
      • 14.3.3.1. CNIO biobank receives EUR 800,000 from the EU

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. AMS Biotechnology (Europe) Limited
    • 15.1.2. ASKION GmbH
    • 15.1.3. Avantor, Inc.
    • 15.1.4. Azenta Life Sciences
    • 15.1.5. Bay Biosciences LLC
    • 15.1.6. Becton, Dickinson and Company
    • 15.1.7. BioIVT LLC
    • 15.1.8. BioKryo by L'AIR LIQUIDE S.A.
    • 15.1.9. BocaBio
    • 15.1.10. Charles River Laboratories International, Inc.
    • 15.1.11. Cryoport Systems, LLC
    • 15.1.12. CTIBiotech
    • 15.1.13. Cureline, Inc.
    • 15.1.14. Firalis Group
    • 15.1.15. Greiner AG
    • 15.1.16. Hamilton Company
    • 15.1.17. Merck KgaA
    • 15.1.18. Micronic Holding B.V.
    • 15.1.19. PHC Holdings Corporation
    • 15.1.20. Promega Corporation
    • 15.1.21. ProteoGenex
    • 15.1.22. QIAGEN N.V.
    • 15.1.23. Sopachem NV/SA
    • 15.1.24. SPT Labtech Ltd.
    • 15.1.25. STEMCELL Technologies Inc.
    • 15.1.26. Taylor-Wharton
    • 15.1.27. Tecan Trading AG
    • 15.1.28. Thermo Fisher Scientific Inc.
    • 15.1.29. UK Biobank Limited
    • 15.1.30. US Biolab Corporation, Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOBANKING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOBANKING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BIOBANKING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BIOBANKING MARKET DYNAMICS
  • FIGURE 7. BIOBANKING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. BIOBANKING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
  • FIGURE 10. BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2022 VS 2030 (%)
  • FIGURE 12. BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. BIOBANKING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 14. BIOBANKING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. BIOBANKING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 16. BIOBANKING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 20. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 26. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 237. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 238. BIOBANKING MARKET LICENSE & PRICING